Pace® Life Sciences published an Outsourced Pharma article examining the impact and key considerations for implementation of USP <86> recombinant testing methods.
Published
Signal category
Research & Knowledge
Quote
“In her latest Outsourced Pharma article, Jillian Miller examines the chapter's impact and key considerations for implementation.”
— Pace® Life Sciences team
Company
Pace® Life Sciences
Transforming Drug Development with Full-Service CDMO Expertise and Analytical Testing
- Industry
- Pharmaceutical Manufacturing
- Location
- Oakdale, US
- Company size
- 441 employees
At Pace® Life Sciences, our people are driven by purpose, advancing science to improve lives across the pharmaceutical, biopharmaceutical, and gene therapy industries. We offer full-service CMC development, CTM manufacturing, regulatory compliance, consulting, and facility support from our nationwide network of CDMO sites, FDA-registered GMP labs, and service centers. Backed by highly trained experts and cutting-edge facilities, we accelerate client programs from clinic to commercialization, with flexibility, speed, and precision. Above all, we deliver reliable results and outstanding client experiences.
Founded 2006